Finally, hEag1 expression has been proposed as the basis of a potential new therapeutic target, due to its restricted expression outside the central nervous system and the effects of hEag1 inhibition on the proliferation of several tumor cell types in vitro [11,23] and in vivo [9,20]. Here, KCNH1 is linked to neoplasm.